|
RACGAP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.202800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.532200E-01 |
| Normal-vs-Stage2 |
6.551600E-02 |
| Normal-vs-Stage3 |
4.004000E-01 |
| Normal-vs-Stage4 |
7.364800E-01 |
| Stage1-vs-Stage2 |
1.120420E-01 |
| Stage1-vs-Stage3 |
9.298400E-01 |
| Stage1-vs-Stage4 |
1.582780E-01 |
| Stage2-vs-Stage3 |
1.736380E-01 |
| Stage2-vs-Stage4 |
2.933500E-02 |
| Stage3-vs-Stage4 |
2.085200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.967600E-01 |
| Normal-vs-AfricanAmerican |
3.903000E-01 |
| Normal-vs-Asian |
8.426200E-01 |
| Caucasian-vs-AfricanAmerican |
4.970400E-01 |
| Caucasian-vs-Asian |
7.964400E-01 |
| AfricanAmerican-vs-Asian |
4.080400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.630400E-01 |
| Normal-vs-Female |
3.082000E-01 |
| Male-vs-Female |
8.230400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.819200E-01 |
| Normal-vs-Age(41-60Yrs) |
8.342100E-02 |
| Normal-vs-Age(61-80Yrs) |
5.287800E-01 |
| Normal-vs-Age(81-100Yrs) |
2.709800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.292000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.883400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.411790E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.544770E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.429220E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.206190E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.737400E-01 |
| Classical-VS-Follicular |
8.40959999970359E-07 |
| Classical-VS-Other |
1.546770E-01 |
| Classical-VS-Normal |
8.868000E-01 |
| Tall-VS-Follicular |
1.010620E-04 |
| Tall-VS-Other |
8.783900E-02 |
| Tall-VS-Normal |
4.796600E-01 |
| Follicular-VS-Other |
8.653600E-01 |
| Follicular-VS-Normal |
2.455100E-03 |
| Other-VS-Normal |
2.252600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.931800E-02 |
| Normal-vs-N1 |
2.833600E-01 |
| N0-vs-N1 |
7.555600E-01 |
|
|
